Livongo Announces Preliminary First Quarter 2020 Revenue; Exceeds Previously Announced Guidance
07 Abril 2020 - 9:00AM
Livongo Health, Inc., (Nasdaq: LVGO) today announced a preliminary
financial result for the first quarter of fiscal year 2020.
Livongo now expects revenue for the first
quarter of 2020 to be in the range of $65.5 million to $66.5
million, versus prior guidance of $60.0 million to $62.0 million.
This financial result for the first quarter of fiscal 2020 is
preliminary and subject to change in connection with the completion
of the company’s quarter-end closing process and the preparation of
the unaudited financial statements for the first quarter of 2020.
The company continues to closely monitor the situation relating to
the COVID-19 virus and any potential impact it could have on
Clients and Members.
“We began 2020 well positioned to pursue our
mission of empowering people with chronic conditions to live better
and healthier lives, and now more than ever, our efforts are
necessary to support our Members and Clients through the COVID-19
pandemic,” said Zane Burke, Chief Executive Officer of Livongo.
“Our record Client launches of over 620 in the first quarter and
Member enrollment are ahead of expectations and we continue to see
strong demand in our pipeline. Livongo is in the unique position of
providing assistance to some of the most vulnerable populations,
people with chronic conditions, and according to last week’s CDC
report, 78 percent of people who were admitted to the intensive
care unit due to COVID-19 had at least one pre-existing health
condition1. Livongo’s remote monitoring and 24/7 telehealth
capabilities provide a world-class health and care experience that
empowers people to stay healthy, at-home, and out of harm’s
way.”
Livongo management will hold a conference call
on Wednesday, May 6, 2020, at 4:30 p.m. Eastern Time to discuss
results for the first quarter ended March 31, 2020 and forward
guidance, which will also be issued in a press release after close
of the U.S. stock market.
All interested parties may dial 270-215-9499 and
reference “Livongo” to listen to the quarterly conference call.
Participants may join the webcast here. A replay of the call will
be available via webcast for on-demand listening shortly after
completion of the call on the Investor Relations section of the
company’s website, www.livongo.com, and will remain available for
approximately 90 days.
About Livongo
Livongo empowers people with chronic conditions
to live better and healthier lives, beginning with diabetes and now
including hypertension, weight management, diabetes prevention, and
behavioral health. Livongo pioneered the category of Applied Health
Signals to offer Members clinically-based insights that focus on
the whole person and make it easier to stay healthy. Using its
AI+AI engine, Livongo’s team of data scientists aggregate and
interpret substantial amounts of health data and information to
create actionable, personalized and timely health signals delivered
to Livongo Members exactly when and where they need them. The
Livongo approach delivers better clinical and financial outcomes
while creating a different and better experience for people with
chronic conditions. For more information, visit: www.livongo.com or
engage with Livongo on LinkedIn or Twitter.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. Forward-looking statements generally relate to
future events or Livongo’s future financial or operating
performance. In some cases, you can identify forward looking
statements because they contain words such as “may,” “will,”
“should,” “expects,” “plans,” “anticipates,” “going to,” “could,”
“intends,” “target,” “projects,” “contemplates,” “believes,”
“estimates,” “predicts,” “potential” or “continue” or the negative
of these words or other similar terms or expressions that concern
Livongo’s expectations, strategy, priorities, plans or intentions.
Forward-looking statements in this release include, but are not
limited to, statements regarding Livongo’s ability to grow and
expand its platform, number of clients, number of members, and
anticipated enrollment rates, Livongo’s ability to provide a
world-class health and care experience for members during the
COVID-19 pandemic, Livongo’s expectations regarding pipeline
demand, and Livongo’s future financial and operating performance,
including its anticipated revenue for the first quarter of fiscal
2020. Livongo’s expectations and beliefs regarding these matters
may not materialize, and actual results in future periods are
subject to risks and uncertainties that could cause actual results
to differ materially from those projected, including risks
regarding Livongo’s ability to retain clients and sell additional
solutions to new and existing clients, Livongo’s ability to attract
and enroll new members, the growth and success of Livongo’s
partners and reseller relationships, Livongo’s ability to estimate
the size of its target market, uncertainty in the healthcare
regulatory environment, the impact of the COVID-19 pandemic on
Livongo’s business and general economic conditions, and Livongo’s
future financial performance, including trends in revenue, costs of
revenue, gross profit or gross margin, operating expenses, paying
clients, and free cash flow. The forward-looking statements
contained in this release are also subject to other risks and
uncertainties, including those more fully described in Livongo’s
filings with the Securities and Exchange Commission, including
Livongo’s Annual Report on Form 10-K for the year ended December
31, 2019. Livongo’s SEC filings are available on the Investor
Relations section of Livongo’s website at ir.livongo.com and on the
SEC’s website at www.sec.gov. The forward-looking statements in
this release are based on information available to Livongo as of
the date hereof, and Livongo disclaims any obligation to update any
forward-looking statements, except as required by law.
Investor Contact:John
HallockInvestor-relations@livongo.com 617-615-7712
Media Contact:Jake
MazankePress@livongo.com630-640-5253
1 Preliminary Estimates of the Prevalence of Selected Underlying
Health Conditions Among Patients with Coronavirus Disease 2019 —
United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly
Rep 2020;69:382–386. DOI:
http://dx.doi.org/10.15585/mmwr.mm6913e2external icon
Livongo Health (NASDAQ:LVGO)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Livongo Health (NASDAQ:LVGO)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024